Stay updated on Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial

Sign up to get notified when there's something new on the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Updated the PubMed publications description and added a revision label; core study data, endpoints, and eligibility criteria remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-25T13:59:35.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page no longer displays the general funding/operating status notice. The core study information and links remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:27:09.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The new screenshot shows minor UI/layout adjustments on the study page with no changes to core study content such as title, eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-10-27T21:05:54.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Updated operating-status notice and version to v3.2.0; removed v3.1.0 tag.
    Difference
    3%
    Check dated 2025-10-06T08:20:27.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    - Updated the revision/version from v3.0.2 to v3.1.0, indicating a new release.
    Difference
    0.1%
    Check dated 2025-09-29T04:54:05.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; removal of a Back to Top link. No substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-14T22:47:40.000Z thumbnail image

Stay in the know with updates to Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page.